Volume 88, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Chloroquine (CQ) is officially used for the primary treatment of malaria in Honduras. In this study, the therapeutic efficacy of CQ for the treatment of uncomplicated malaria in the municipality of Puerto Lempira, Gracias a Dios, Honduras was evaluated using the Pan American Health Organization—World Health Organization protocol with a follow-up of 28 days. Sixty-eight patients from 6 months to 60 years of age microscopically diagnosed with uncomplicated malaria were included in the final analysis. All patients who were treated with CQ (25 mg/kg over 3 days) cleared parasitemia by day 3 and acquired no new infection within 28 days of follow-up. All the parasite samples sequenced for CQ resistance mutations () showed only the CQ-sensitive genotype (CVMNK). This finding shows that CQ remains highly efficacious for the treatment of uncomplicated malaria in Gracias a Dios, Honduras.


Article metrics loading...

Loading full text...

Full text loading...



  1. Peters W, , 1971. Malaria. Chemoprophylaxis and chemotherapy. BMJ 2: 9598.[Crossref]
  2. Ferraroni JJ, Alencar FH, Shrimpton R, , 1983. Multiple drug resistance in falciparum malaria from Brazil. Trans R Soc Trop Med Hyg 77: 138139.[Crossref]
  3. Comer RD, Young MD, Porter JA, Jr Gauld JR, Merritt W, , 1968. Chloroquine resistance in Plasmodium falciparum malaria on the Pacific coast of Colombia. Am J Trop Med Hyg 17: 795799.
  4. Marquino W, MacArthur JR, Barat LM, Oblitas FE, Arrunategui M, Garavito G, Chafloque ML, Pardave B, Gutierrez S, Arrospide N, Carrillo C, Cabezas C, Ruebush TK, 2nd, 2003. Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru. Am J Trop Med Hyg 68: 120123.
  5. Caraballo A, Rodriguez-Acosta A, , 1999. Chemotherapy of malaria and resistance to antimalarial drugs in Guyana area, Venezuela. Am J Trop Med Hyg 61: 120124.
  6. Oostburg BF, , 1973. Chloroquin-resistant tropical malaria in south Surinam. Ned Tijdschr Geneeskd 117: 693694.
  7. Ache A, Escorihuela M, Vivas E, Paez E, Miranda L, Matos A, Perez W, Diaz O, Izarra E, , 2002. In vivo drug resistance of falciparum malaria in mining areas of Venezuela. Trop Med Int Health 7: 737743.[Crossref]
  8. Cortese JF, Caraballo A, Contreras CE, Plowe CV, , 2002. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Infect Dis 186: 9991006.[Crossref]
  9. Marquino W, Huilca M, Calampa C, Falconi E, Cabezas C, Naupay R, Ruebush TK, 2nd, 2003. Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru. Am J Trop Med Hyg 68: 608612.
  10. Secretaria de Salud de Honduras, 2010. Norma de Malaria en Honduras. Secretaria de Salud SdRP, Direccion General de Promocion de la Salud, Programa Nacional de la Prevencion y Control de la Malaria. Tegucigalpa, Honduras: Secretaria de Salud de Honduras.
  11. Samudio F, Santamaria AM, Obaldia N, 3rd Pascale JM, Bayard V, Calzada JE, , 2005. Prevalence of Plasmodium falciparum mutations associated with antimalarial drug resistance during an epidemic in Kuna Yala, Panama, Central America. Am J Trop Med Hyg 73: 839841.
  12. WHO, 2010. World Malaria Report: Global Malaria Programme. Geneva: World Health Organization.
  13. Pan American Health Organization, 2012. PAHO Health Information Platform-Malaria Surveillance Indicators. Available at: www.paho.org/malariastats. Accessed February 10, 2012
  14. National Malaria Programme, 2011. Situation Report of Malaria in 2011: National Malaria Programme. Tegucigalpa, Honduras: Ministry of Health.
  15. Nguyen-Dinh P, Hobbs JH, Campbell CC, , 1981. Assessment of chloroquine sensitivity of Plasmodium falciparum in Choluteca, Honduras. Bull World Health Organ 59: 641646.
  16. Warsame M, Kimbute O, Machinda Z, Ruddy P, Melkisedick M, Peto T, Ribeiro I, Kitua A, Tomson G, Gomes M, , 2007. Recognition, perceptions and treatment practices for severe malaria in rural Tanzania: implications for accessing rectal artesunate as a pre-referral. PLoS One 2: e149.[Crossref]
  17. World Health Organization/Pan American Health Organization, 1998. Assessment of Therapeutic Efficacy of Medicaments to Treat Uncomplicated P. falciparum malaria in the Americas. Report No.: PS/HCP/HCT/113/98. Washington, DC: WHO, OPS.
  18. Bereczky S, Martensson A, Gil JP, Farnert A, , 2005. Short report: rapid DNA extraction from archive blood spots on filter paper for genotyping of Plasmodium falciparum . Am J Trop Med Hyg 72: 249251.
  19. Singh B, Bobogare A, Cox-Singh J, Snounou G, Abdullah MS, Rahman HA, , 1999. A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am J Trop Med Hyg 60: 687692.
  20. Fontecha GA, Mendoza M, Banegas E, Poorak M, De Oliveira AM, Mancero T, Udhayakumar V, Lucchi NW, Mejia RE, , 2012. Comparison of molecular tests for the diagnosis of malaria in Honduras. Malar J 11: 119.[Crossref]
  21. Griffing S, Syphard L, Sridaran S, McCollum AM, Mixson-Hayden T, Vinayak S, Villegas L, Barnwell JW, Escalante AA, Udhayakumar V, , 2010. pfmdr1 amplification and fixation of pfcrt chloroquine resistance alleles in Plasmodium falciparum in Venezuela. Antimicrob Agents Chemother 54: 15721579.
  22. Butler WP, Roberts DR, , 2000. Malaria in the Americas: a model of reemergence. Mil Med 165: 897902.
  23. PAHO, 2001. Situation of malaria programs in the Americas. Epidemiol Bull 22: 1014.
  24. Le Jouan M, Jullien V, Tetanye E, Tran A, Rey E, Treluyer JM, Tod M, Pons G, , 2005. Quinine pharmacokinetics and pharmacodynamics in children with malaria caused by Plasmodium falciparum . Antimicrob Agents Chemother 49: 36583662.[Crossref]
  25. Francis D, Nsobya SL, Talisuna A, Yeka A, Kamya MR, Machekano R, Dokomajilar C, Rosenthal PJ, Dorsey G, , 2006. Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. J Infect Dis 193: 978986.[Crossref]
  26. Aubouy A, Bakary M, Keundjian A, Mbomat B, Makita JR, Migot-Nabias F, Cot M, Le Bras J, Deloron P, , 2003. Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children. Antimicrob Agents Chemother 47: 231237.[Crossref]
  27. Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Tichit M, Jahevitra M, Rabearimanana S, Raherinjafy R, Mercereau-Puijalon O, Durand R, Menard D, , 2010. Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar. PLoS One 5: e13281.[Crossref]
  28. Das MK, Lumb V, Mittra P, Singh SS, Dash AP, Sharma YD, , 2010. High chloroquine treatment failure rates and predominance of mutant genotypes associated with chloroquine and antifolate resistance among falciparum malaria patients from the island of Car Nicobar, India. J Antimicrob Chemother 65: 12581261.[Crossref]
  29. World Health Organization, 1996. Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. WHO Document No. WHO/MAL/96.1077. Geneva: World Health Organization.
  30. Jovel IT, Mejia RE, Banegas E, Piedade R, Alger J, Fontecha G, Ferrreira PE, Veiga MI, Enamorado IG, Bjorkman A, Ursing J, , 2011. Drug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America. Malar J 10: 376.[Crossref]
  31. WHO, 2010. Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000–2010. Geneva: World Health Organization.
  32. Neuberger A, Zhong K, Kain KC, Schwartz E, , 2012. Lack of evidence for chloroquine-resistant Plasmodium falciparum Malaria, Leogane, Haiti. Emerg Infect Dis 18: 14871489.[Crossref]

Data & Media loading...

  • Received : 31 Oct 2012
  • Accepted : 30 Nov 2012

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error